These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2731483)

  • 1. Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.
    Matsumura M; Saito S
    Endocrinol Jpn; 1989 Feb; 36(1):15-21. PubMed ID: 2731483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bile salts on plasma concentration of beta-endorphin-like immunoreactivity in men.
    Matsumura M; Shimizu I; Ohura M; Mori H; Saito S
    Dig Dis Sci; 1988 Jun; 33(6):692-6. PubMed ID: 2967167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric and intestinal release of vasoactive intestinal polypeptide in the milk-fed lamb.
    Reid AM; Shulkes A; Titchen DA
    Regul Pept; 1985 Sep; 12(1):43-50. PubMed ID: 4070686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma secretin in response to pure bile salts and endogenous bile in man.
    Bondesen S; Christensen H; Lindorff-Larsen K; Schaffalitzky de Muckadell OB
    Dig Dis Sci; 1985 May; 30(5):440-4. PubMed ID: 3987477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive secretin release following taurocholate perfusions of the cat duodenum.
    Hanssen LE; Hotz J; Hartmann W; Nehls W; Goebell H
    Scand J Gastroenterol; 1980; 15(1):89-95. PubMed ID: 7367827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of local mechanism involvement in vasoactive intestinal polypeptide release from canine small intestine.
    Chijiiwa Y; Misawa T; Ibayashi H
    Gastroenterology; 1986 Jun; 90(6):1877-81. PubMed ID: 2870952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of VIP, secretin and motilin after duodenal acidification in man.
    Bloom SR; Mitchell SJ; Greenberg GR; Christofides N; Domschke W; Domschke S; Mitznegg P; Demling L
    Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):365-8. PubMed ID: 726803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intraduodenal bile and taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of vasoactive intestinal polypeptide and somatostatin in man.
    Riepl RL; Fiedler F; Teufel J; Lehnert P
    Pancreas; 1994 Jan; 9(1):109-16. PubMed ID: 7509061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis.
    Duan RD; Cheng Y; Tauschel HD; Nilsson A
    Dig Dis Sci; 1998 Jan; 43(1):26-32. PubMed ID: 9508530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of vasoactive intestinal polypeptide in plasma.
    Burhol PG; Lygren I; Waldum HL
    Scand J Gastroenterol; 1978; 13(7):807-13. PubMed ID: 725503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.
    Huang YL; Yu JP; Wang GH; Chen ZH; Wang Q; Xiao L
    World J Gastroenterol; 2007 Dec; 13(45):6060-5. PubMed ID: 18023100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human colonic adenylate cyclase: effects of bile acids.
    Simon B; Cyzgan P; Stiehl A; Kather H
    Eur J Clin Invest; 1978 Oct; 8(5):321-3. PubMed ID: 103725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of solution of low pH and taurocholate on release of beta-endorphin-like immunoreactivity from human duodenal mucosa in vitro.
    Matsumura M; Saito S; Fujino M
    Regul Pept; 1982 Mar; 3(3-4):173-81. PubMed ID: 6281854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and release of immunoreactive vasoactive intestinal polypeptide in bovine adrenal medulla.
    Yoshikawa M; Saito H; Sano T; Ohuchi T; Ishimura Y; Morita K; Saito S; Oka M
    Neurosci Lett; 1990 Mar; 111(1-2):75-9. PubMed ID: 2336195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.